BackHumana Overview
Humana Inc.

Humana Target Price

Where could HUM trade next? Consensus target price: $460.

Get informed when a big investor buys or sells

+ Follow

Share Price

$422.07

Average Target Price

$460.379.1% upside

27 analysts in the last 4 months

High: $596 | Low: $300

Analyst Recommendations

No recommendations in the last 4 months.

Revenue & Income Forecast

Analysts' Target Prices

DateAnalystPrice TargetCurrent Upside/Downside
2026-10-13Mizuho Securities$49517.3% upsideOpen
2026-10-12Raymond James$52023.2% upsideOpen
2026-10-12Truist FinancialDavid MacDonald$47512.5% upsideOpen
2026-10-12Oppenheimer$52524.4% upsideOpen
2026-10-12UBS$49517.3% upsideOpen
2026-10-09Oppenheimer$47512.5% upsideOpen
2026-10-09UBS$59641.2% upsideOpen
2026-10-09Robert W. BairdMichael Ha$59641.2% upsideOpen
2026-10-09Barclays$58237.9% upsideOpen
2026-10-07Raymond JamesSarah James$4609% upsideOpen
2026-09-25Barclays$51522% upsideOpen
2026-08-24Wolfe ResearchJustin Lake$4506.6% upsideOpen
2026-08-04Morgan Stanley$37012.3% downsideOpen
2026-07-31Barclays$4073.6% downsideOpen
2026-07-30Robert W. Baird$3907.6% downsideOpen
2026-07-30Leerink Partners$51321.5% upsideOpen
2026-07-30Guggenheim$47111.6% upsideOpen
2026-07-30OppenheimerMichael Wiederhorn$4054% downsideOpen
2026-07-30UBS$4054% downsideOpen
2026-07-30Piper Sandler$4639.7% upsideOpen
2026-07-29Evercore ISI$48013.7% upsideOpen
2026-07-20Jefferies$4102.9% downsideOpen
2026-07-14Truist FinancialDavid MacDonald$4151.7% downsideOpen
2026-07-13Wells FargoStephen Baxter$50218.9% upsideOpen
2026-07-09RBC Capital$4151.7% downsideOpen
2026-07-07Cantor Fitzgerald$30028.9% downsideOpen
2026-07-07Raymond JamesSarah James$30028.9% downsideOpen
2026-06-08Mizuho Securities$3907.6% downsideOpen
2026-06-04Morgan Stanley$24941% downsideOpen
2026-06-03Bernstein$4250.7% upsideOpen
2026-06-01Truist FinancialDavid MacDonald$32024.2% downsideOpen
2026-05-26Barclays$34418.5% downsideOpen
2026-05-22UBS$32024.2% downsideOpen
2026-05-20Mizuho Securities$33520.6% downsideOpen
2026-05-20Deutsche Bank$4414.5% upsideOpen
2026-05-15Morgan StanleyErin Wright$21748.6% downsideOpen
2026-05-13Piper Sandler$25439.8% downsideOpen
2026-05-01Raymond James$26038.4% downsideOpen
2026-04-30Barclays$18057.4% downsideOpen
2026-04-30UBS$26237.9% downsideOpen
2026-04-30Guggenheim$26936.3% downsideOpen
2026-04-30Truist FinancialDavid MacDonald$27036% downsideOpen
2026-04-30Oppenheimer$26038.4% downsideOpen
2026-04-30Deutsche Bank$23544.3% downsideOpen
2026-04-30RBC CapitalBen Hendrix$24641.7% downsideOpen
2026-04-08Evercore ISI$19553.8% downsideOpen
2026-04-08Mizuho Securities$25838.9% downsideOpen
2026-02-18Wells Fargo$20651.2% downsideOpen
2026-02-17Truist Financial$20052.6% downsideOpen
2026-02-13Deutsche BankGeorge Hill$18057.4% downsideOpen

Humana (HUM) FAQ

Humana (HUM) currently reports a target price of $460. Use the charts on this page to explore Humana's target price history and peer comparisons.

Analysts' average 12-month price target for Humana is $460, about 9.1% upside from the current share price of $422.07. That spread summarizes where covering analysts expect the stock could trade over the next year, not a guarantee. Review the individual firm targets on this page — a wide high-to-low range often means opinion is split.

Start with the current target price of $460, then check the historical chart for trend and the peer comparison chart for relative positioning. From there, open related valuation or income-statement pages for Humana, and consider following HUM for alerts when major investors trade the stock.

Humana is classified in the Healthcare sector. On target price, it currently shows $460. Sector peers often share similar capital intensity and growth regimes, so relative rankings inside Healthcare are usually more informative than comparing HUM with unrelated industries.